Biodesix Share Price Today
(NASDAQ: BDSX)

Name: Biodesix Share Price Today (NASDAQ: BDSX) - Biodesix Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Biodesix share price is $0.87 & ₹75.66 as on 6 Mar 2025, 2.30 'hrs' IST

$0.87

▲

0.15

(20.83%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Biodesix share price in Dollar and Rupees. Guide to invest in Biodesix stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Biodesix, along with analyst recommendations, forecasts, and comprehensive financials.

Biodesix share price movements

Today's Low: $0.71
Today's High: $0.96
$0.87
18.39%
Downside
Day's Volatility :25.76%
Upside
9.03%
52 Weeks Low: $0.64
52 Weeks High: $2.04
$0.87
27.01%
Downside
52 Weeks Volatility :68.87%
Upside
57.35%

Biodesix (BDSX) Returns

Period	Biodesix Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-33.59%	3.7%	0.0%
6 Months	-52.97%	-2.8%	0.0%
1 Year	-43.14%	2.5%	0.0%
3 Years	-60.09%	12.9%	-11.6%

Biodesix (BDSX) Key Statistics

in dollars & INR

Previous Close	$0.72
Open	$0.74
Today's High	$0.9564
Today's Low	$0.71
Market Capitalization	$104.7M
Today's Volume	$870.5K
52 Week High	$2.04
52 Week Low	$0.635
Revenue TTM	$65.6M
EBITDA	$-29.3M
Earnings Per Share (EPS)	$-0.37
Profit Margin	-66.84%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-331.82%

How to invest in Biodesix Stock (BDSX) from India?

It is very easy for Indian residents to invest directly in Biodesix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biodesix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biodesix or BDSX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biodesix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biodesix shares which would translate to 1.000 fractional shares of Biodesix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biodesix, in just a few clicks!

Returns in Biodesix (BDSX) for Indian investors in Rupees

The Biodesix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Biodesix investment value today

Current value as on today

₹61,812

Returns

₹38,188

(-38.19%)

Returns from Biodesix Stock

₹43,137 (-43.14%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Biodesix (BDSX)

-70%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Biodesix Stock from India on INDmoney has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Biodesix

Telemark Asset Management, LLC
5.69%
AIGH Capital Management, LLC
4.25%
Bryn Mawr Trust Company
4.19%
Birchview Capital, LP
3.84%
SILVERARC CAPITAL MANAGEMENT, LLC
2.98%
Vanguard Group Inc
2.63%

Analyst Recommendation on Biodesix

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Biodesix(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Biodesix Stock (BDSX)

What analysts predicted

Upside of 256.32%

Target:

$3.10

Current:

$0.87

Insights on Biodesix Stock (Ticker Symbol: BDSX)

Price Movement
In the last 7 days, BDSX stock has moved up by 7.0%
Increasing Revenue
Revenue is up for the last 7 quarters, 9.05M → 18.15M (in $), with an average increase of 10.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -13.61M → -10.25M (in $), with an average increase of 15.7% per quarter
BDSX vs TMO (1 yr)
In the last 1 year, Biodesix Inc has experienced a drawdown of -43.1%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 31.7%
BDSX vs TMO (3 yr)
In the last 3 years, Biodesix Inc has experienced a drawdown of -60.5%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 56.3%
Price to Sales
ForBDSX every $1 of sales, investors are willing to pay $1.5, whereas for Thermo Fisher Scientific, Inc., the investors are paying $4.7 for every $1 of sales.

BDSX Biodesix Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$24.6M	↑ 20.16%
Net Income	$-31.4M	↑ 19.83%
Net Profit Margin	-127.71%	↑ 0.35%

	FY20	Y/Y Change
Revenue	$45.6M	↑ 85.55%
Net Income	$-36.5M	↑ 16.32%
Net Profit Margin	-80.06%	↑ 47.65%

	FY21	Y/Y Change
Revenue	$54.5M	↑ 19.64%
Net Income	$-44.5M	↑ 21.95%
Net Profit Margin	-81.61%	↓ 1.55%

	FY22	Y/Y Change
Revenue	$38.2M	↓ 29.89%
Net Income	$-80.4M	↑ 80.73%
Net Profit Margin	-210.37%	↓ 128.76%

	FY23	Y/Y Change
Revenue	$49.1M	↑ 28.46%
Net Income	$-52.1M	↓ 35.13%
Net Profit Margin	-106.23%	↑ 104.14%

	FY24	Y/Y Change
Revenue	$71.3M	↑ 45.3%
Net Income	$-42.9M	↓ 17.67%
Net Profit Margin	-60.19%	↑ 46.04%

	Q2 FY23	Q/Q Change
Revenue	$11.9M	↑ 31.1%
Net Income	$-13.4M	↓ 21.97%
Net Profit Margin	-112.5%	↑ 76.5%

	Q3 FY23	Q/Q Change
Revenue	$13.5M	↑ 13.64%
Net Income	$-10.9M	↓ 18.02%
Net Profit Margin	-81.16%	↑ 31.34%

	Q4 FY23	Q/Q Change
Revenue	$14.7M	↑ 8.72%
Net Income	$-9.1M	↓ 16.53%
Net Profit Margin	-62.31%	↑ 18.85%

	Q1 FY24	Q/Q Change
Revenue	$14.8M	↑ 1.02%
Net Income	$-13.6M	↑ 48.97%
Net Profit Margin	-91.87%	↓ 29.56%

	Q2 FY24	Q/Q Change
Revenue	$17.9M	↑ 20.97%
Net Income	$-10.8M	↓ 20.61%
Net Profit Margin	-60.3%	↑ 31.57%

	Q3 FY24	Q/Q Change
Revenue	$18.2M	↑ 1.26%
Net Income	$-10.3M	↓ 5.09%
Net Profit Margin	-56.51%	↑ 3.79%

	FY19	Y/Y Change
Profit	$18.5M	↑ 15.3%

	FY20	Y/Y Change
Profit	$23.6M	↑ 27.5%

	FY21	Y/Y Change
Profit	$24.0M	↑ 1.82%

	FY22	Y/Y Change
Profit	$24.1M	↑ 0.29%

	FY23	Y/Y Change
Profit	$36.1M	↑ 49.96%

	FY24	Y/Y Change
Profit	$71.3M	↑ 97.7%

	Q2 FY23	Q/Q Change
Profit	$8.6M	↑ 46.66%

	Q3 FY23	Q/Q Change
Profit	$10.3M	↑ 18.86%

	Q4 FY23	Q/Q Change
Profit	$11.3M	↑ 10.06%

	Q1 FY24	Q/Q Change
Profit	$11.6M	↑ 3.09%

	Q2 FY24	Q/Q Change
Profit	$14.0M	↑ 20.66%

	Q3 FY24	Q/Q Change
Profit	$14.0M	↓ 0.54%

	FY19	Y/Y Change
Operating Cash Flow	$-21.7M	↑ 22.91%
Investing Cash Flow	$-1.9M	↑ 203.4%
Financing Cash Flow	$23.0M	↑ 20.7%

	FY20	Y/Y Change
Operating Cash Flow	$-21.4M	↓ 1.66%
Investing Cash Flow	$-2.9M	↑ 56.36%
Financing Cash Flow	$81.1M	↑ 253.17%

	FY21	Y/Y Change
Operating Cash Flow	$-28.2M	↑ 32.09%
Investing Cash Flow	$-2.5M	↓ 12.98%
Financing Cash Flow	$1.3M	↓ 98.44%

	FY22	Y/Y Change
Operating Cash Flow	$-45.0M	↑ 59.35%
Investing Cash Flow	$-3.5M	↑ 38.75%
Financing Cash Flow	$58.9M	↑ 4565.77%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$937.0K	↓ 112.19%
Investing Cash Flow	$-6.5M	↑ 0.0%
Financing Cash Flow	$-2.3M	↓ 3.76%

Biodesix Technicals Summary

Sell

Neutral

Buy

Biodesix is currently in a neutral trading position according to technical analysis indicators.

Biodesix (BDSX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biodesix Inc	-13.0%	-52.97%	-43.14%	-60.09%	-93.21%
Agilent Technologies Inc.	-13.96%	-8.56%	-13.48%	-2.94%	78.81%
Idexx Laboratories, Inc.	-5.98%	-6.81%	-21.57%	-15.48%	80.06%
Thermo Fisher Scientific, Inc.	-9.71%	-13.63%	-11.38%	-1.97%	77.48%
Danaher Corp.	-2.07%	-20.46%	-16.74%	-19.95%	48.71%
Iqvia Holdings Inc.	-7.09%	-25.1%	-26.53%	-14.22%	49.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biodesix Inc	NA	NA	NA	0.0	-3.32	-0.23	NA	0.19
Agilent Technologies Inc.	29.02	29.02	2.0	5.57	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	41.39	41.39	4.36	11.97	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	31.65	31.65	2.02	23.33	0.13	0.05	0.0	130.22
Danaher Corp.	38.92	38.92	2.05	7.65	0.08	0.04	0.01	68.9
Iqvia Holdings Inc.	24.81	24.81	0.98	11.89	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biodesix Inc	Buy	$104.7M	-93.21%	NA	-66.84%
Agilent Technologies Inc.	Buy	$36.1B	78.81%	29.02	19.27%
Idexx Laboratories, Inc.	Buy	$35.9B	80.06%	41.39	22.78%
Thermo Fisher Scientific, Inc.	Buy	$194.9B	77.48%	31.65	14.77%
Danaher Corp.	Buy	$147.2B	48.71%	38.92	16.33%
Iqvia Holdings Inc.	Buy	$32.8B	49.88%	24.81	8.91%

About Biodesix

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Organization	Biodesix
Employees	217
CEO	Mr. Scott Hutton
Industry	Health Services

Management People of Biodesix

Name	Title
Mr. Scott Hutton	President, CEO & Director
Ms. Robin Harper Cowie	CFO, Secretary & Treasurer
Mr. Kieran O'Kane	Chief Commercial Officer
Dr. Heinrich Röder	Founder & CTO
Ms. Jessica Olbricht	Senior Director of Human Resources
Dr. Gary Anthony Pestano Ph.D.	Chief Development Officer
Ms. Bobbi Coffin	Chief Growth Officer
Dr. James R. Jett M.D.	Co-Chief Medical Officer
Dr. Steven C. Springmeyer	Co-Chief Medical Officer
Mr. Christopher Vazquez	VP & Controller

Important FAQs about investing in BDSX Stock from India :

What is Biodesix share price today?

Biodesix share price today stands at $0.87, Open: $0.74 ; Previous Close: $0.72 ; High: $0.96 ; Low: $0.71 ; 52 Week High: $2.04 ; 52 Week Low: $0.64.

The stock opens at $0.74, after a previous close of $0.72. The stock reached a daily high of $0.96 and a low of $0.71, with a 52-week high of $2.04 and a 52-week low of $0.64.

Can Indians buy Biodesix shares?

Yes, Indians can invest in the Biodesix (BDSX) from India.

With INDmoney, you can buy Biodesix at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Biodesix at zero transaction cost.

How can I buy Biodesix shares from India?

It is very easy to buy Biodesix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biodesix (BDSX) be purchased?

Yes, you can buy fractional shares of Biodesix with INDmoney app.

What are the documents required to start investing in Biodesix stocks?

To start investing in Biodesix, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.